954 related articles for article (PubMed ID: 12111128)
1. Low-dose dobutamine stress gated SPET for identification of viable myocardium: comparison with stress-rest perfusion SPET and PET.
Yoshinaga K; Katoh C; Noriyasu K; Yamada S; Ito Y; Kuge Y; Kawai Y; Kohya T; Kitabatake A; Tamaki N
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):882-90. PubMed ID: 12111128
[TBL] [Abstract][Full Text] [Related]
2. Low-dose dobutamine electrocardiograph-gated myocardial SPECT for identifying viable myocardium: comparison with dobutamine stress echocardiography and PET.
Yoshinaga K; Morita K; Yamada S; Komuro K; Katoh C; Ito Y; Kuge Y; Kohya T; Kitabatake A; Tamaki N
J Nucl Med; 2001 Jun; 42(6):838-44. PubMed ID: 11390545
[TBL] [Abstract][Full Text] [Related]
3. Dobutamine stress electrocardiography-gated Tc-99m tetrofosmin SPECT for detection of viable but dysfunctional myocardium.
Yamagishi H; Akioka K; Hirata K; Sakanoue Y; Toda I; Yoshiyama M; Teragaki M; Takeuchi K; Yoshikawa J; Ochi H
J Nucl Cardiol; 2001; 8(1):58-67. PubMed ID: 11182710
[TBL] [Abstract][Full Text] [Related]
4. Baseline/post-nitrate Tc-99m tetrofosmin mismatch for the assessment of myocardial viability in patients with severe left ventricular dysfunction: comparison with baseline Tc-99m tetrofosmin scintigraphy/FDG PET imaging.
Giorgetti A; Marzullo P; Sambuceti G; Di Quirico S; Kusch A; Landi P; Salvadori PA; Pisani P; L'abbate A
J Nucl Cardiol; 2004; 11(2):142-51. PubMed ID: 15052245
[TBL] [Abstract][Full Text] [Related]
5. Myocardial viability assessment with gated SPECT Tc-99m tetrofosmin % wall thickening: comparison with F-18 FDG-PET.
Maruyama A; Hasegawa S; Paul AK; Xiuli M; Yoshioka J; Maruyama K; Hori M; Nishimura T
Ann Nucl Med; 2002 Feb; 16(1):25-32. PubMed ID: 11922205
[TBL] [Abstract][Full Text] [Related]
6. Dobutamine stress echocardiography and technetium-99m-tetrofosmin/fluorine 18-fluorodeoxyglucose single-photon emission computed tomography and influence of resting ejection fraction to assess myocardial viability in patients with severe left ventricular dysfunction and healed myocardial infarction.
Rambaldi R; Poldermans D; Bax JJ; Boersma E; Valkema R; Elhendy A; Vletter WB; Fioretti PM; Roelandt JR; Krenning EP
Am J Cardiol; 1999 Jul; 84(2):130-4. PubMed ID: 10426327
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous assessment of myocardial viability and function for the detection of hibernating myocardium using ECG-gated 99Tcm-tetrofosmin emission tomography: a comparison with 201Tl emission tomography combined with cine magnetic resonance imaging.
Gunning MG; Anagnostopoulos C; Davies G; Knight CJ; Pennell DJ; Fox KM; Pepper J; Underwood SR
Nucl Med Commun; 1999 Mar; 20(3):209-14. PubMed ID: 10093069
[TBL] [Abstract][Full Text] [Related]
8. Value of low-dose dobutamine addition to routine dual isotope gated SPECT myocardial imaging in patients with healed myocardial infarction or abnormal wall thickening by echocardiogram.
Heiba SI; Abdel-Dayem HM; Gould R; Bernaski E; Morlote M; El-Zeftawy H; Ambrose JA
Am J Cardiol; 2004 Feb; 93(3):300-6. PubMed ID: 14759378
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of single-injection, single-acquisition 99mTc-MIBI gated SPET and stress-rest perfusion SPET for the evaluation of myocardial viability after bypass surgery in coronary artery disease.
Yoon SN; Lee DS; Chung JK; Lee MC
Eur J Nucl Med; 2000 Dec; 27(12):1747-53. PubMed ID: 11189935
[TBL] [Abstract][Full Text] [Related]
10. Early prediction of regional functional recovery in reperfused myocardium using single-injection resting quantitative electrocardiographic gated SPET.
Kurihara H; Nakamura S; Hatada K; Takehana K; Hamada S; Watanabe J; Yuyama R; Mimura J; Sugiura T; Iwasaka T
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):458-64. PubMed ID: 11914882
[TBL] [Abstract][Full Text] [Related]
11. [Changes in myocardial Tc-99m-sestamibi uptake in asynergic territories during low-dose echo-dobutamine test].
Leoncini M; Marcucci G; Magni M; Silvestri M; Traini AM; Arena A; Mondanelli D; Giovannini T; Paoletti M; Bardazzi L; Mennuti A; Petrella A
G Ital Cardiol; 1996 Nov; 26(11):1243-55. PubMed ID: 9036021
[TBL] [Abstract][Full Text] [Related]
12. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability.
Baer FM; Voth E; Schneider CA; Theissen P; Schicha H; Sechtem U
Circulation; 1995 Feb; 91(4):1006-15. PubMed ID: 7850935
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(16):1-80. PubMed ID: 23074393
[TBL] [Abstract][Full Text] [Related]
14. Low-dose dobutamine gated single-photon emission tomography: comparison with stress echocardiography.
Everaert H; Vanhove C; Franken PR
Eur J Nucl Med; 2000 Apr; 27(4):413-8. PubMed ID: 10805114
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
[TBL] [Abstract][Full Text] [Related]
16. Assessment of perfusion, function, and myocardial metabolism after infarction with a combination of low-dose dobutamine tetrofosmin gated SPECT perfusion scintigraphy and BMIPP SPECT imaging.
Everaert H; Vanhove C; Franken PR
J Nucl Cardiol; 2000; 7(1):29-36. PubMed ID: 10698232
[TBL] [Abstract][Full Text] [Related]
17. Dobutamine-induced contractile reserve in stunned, hibernating, and scarred myocardium in patients with ischemic cardiomyopathy.
Schinkel AF; Bax JJ; van Domburg R; Elhendy A; Valkema R; Vourvouri EC; Sozzi FB; Roelandt JR; Poldermans D
J Nucl Med; 2003 Feb; 44(2):127-33. PubMed ID: 12571199
[TBL] [Abstract][Full Text] [Related]
18. [Head to head comparison of dobutamine alone and combined with nitrate stress echocardiography and 99mTc-MIBI/18FDG myocardial SPECT image for diagnosis of viable myocardium in patients with severe left ventricular dysfunction].
Yang YJ; Yang WX; Shi RF; Hu FH; You SJ; Tian YQ; He ZX; Wang YW; Ye L; Chen JL; Gao RL; Chen ZJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Apr; 33(4):323-7. PubMed ID: 15932661
[TBL] [Abstract][Full Text] [Related]
19. Dobutamine-stress electrocardiographically gated positron emission tomography for detection of viable but dysfunctional myocardium.
Yamagishi H; Akioka K; Hirata K; Sakanoue Y; Toda I; Yoshiyama M; Teragaki M; Takeuchi K; Yoshikawa J; Ochi H
J Nucl Cardiol; 1999; 6(6):626-32. PubMed ID: 10608590
[TBL] [Abstract][Full Text] [Related]
20. Identification of hibernating myocardium: a comparison between dobutamine echocardiography and study of perfusion and metabolism in patients with severe left ventricular dysfunction.
Mariani MA; Palagi C; Donatelli F; Mengozzi G; Biadi O; Vanoli G; Landoni C; Paolini G; Lucignani G; Fazio F
Am J Card Imaging; 1995 Jan; 9(1):1-8. PubMed ID: 7894227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
